Dental Care Clinics in Kingsford, MI Accepting Medicare
3 Dental Care Clinics found. Showing 1 - 3
 Santini Family Dentistry, Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 720 East Blvd, Kingsford, MI 49802 Phone: 906-774-5087 Fax: 906-774-0586 |
Jeneen M Martin Dds Pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 821 Pyle Dr, Kingsford, MI 49802 Phone: 906-774-2505 |
Pauldinglight Pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 844 Pyle Dr, Kingsford, MI 49802 Phone: 906-774-5067 Fax: 906-774-1192 |
News Archive
Adding stroke severity in hospital mortality model may improve prediction of death risk
Adding stroke severity to a hospital 30-day mortality model based on claims data for Medicare beneficiaries with acute ischemic stroke was associated with improvement in predicting the risk of death at 30 days and changes in performance ranking regarding mortality for a considerable proportion of hospitals, according to a study in the July 18 issue of JAMA.
GTx second-quarter net loss increases to $12.9 million
GTx, Inc. today reported financial results for the second quarter of 2010. The net loss for the quarter ended June 30, 2010 was $12.9 million compared with a net loss of $11.3 million for the quarter ended June 30, 2009. The net loss for the second quarter of 2010 included a $1.7 million non-cash impairment charge related to the conclusion of the Phase III clinical trial of toremifene 20 mg.
Researcher and health research journalist point out biased misinformation on coronavirus
In a new JAMA editorial, a Boston University School of Public Health (BUSPH) researcher and a health research journalist outline common ways that media, governments, and industry and academic public relations press releases have incompletely and misleadingly reported coronavirus research, and how they can do better.
FDA extends review of Genasense NDA appeal in chronic lymphocytic leukemia
Genta Incorporated has announced that the Food and Drug Administration (FDA) has extended its review of Genta's appeal of the non- approvable decision for a New Drug Application (NDA) that proposed the use of Genasense (oblimersen sodium injection) plus chemotherapy in patients with relapsed or refractory chronic lymphocytic leukemia.
› Verified 7 days ago